TrialJournal of child and adolescent psychopharmacology2015

Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.

Cristan A Farmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.